Glimpeg PM 2mg/500mg/15mg Tablet SR
Marketer
IGP Mediventures Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimpeg PM 2mg/500mg/15mg Tablet SR
Combiflex DM 2mg/500mg/15mg Extended-Release Tablets are a triple-action formulation managing blood glucose. This medication complements diet and exercise to enhance glycemic control in adult type 2 diabetes patients. It facilitates efficient insulin use, consequently reducing blood sugar. Dosage and treatment length for Combiflex DM 2mg/500mg/15mg ER Tablets should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; avoid doubling the dose. Excessive intake risks hypoglycemia (low blood sugar). Concomitant use with other antidiabetic agents, alcohol, or skipped meals may precipitate hypoglycemia; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before commencing treatment. Similarly, pregnant or lactating individuals require medical consultation. Kidney function assessments precede treatment initiation. Limiting alcohol consumption is advised to mitigate potential side effects.
Uses of Glimpeg PM 2mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimpeg PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Glimpeg PM 2mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Glimpeg PM 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimpeg PM 2mg/500mg/15mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimpeg PM 2mg/500mg/15mg Extended-Release Tablet with a meal.
How Glimpeg PM 2mg/500mg/15mg Tablet SR works:
Glimpeg PM 2mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents—to enhance blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin sensitivity. Pioglitazone, a thiazolidinedione, further enhances insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimpeg PM 2mg/500mg/15mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Glimpeg PM 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Medical advice is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Glimpeg PM tablets (2mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available data from humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glimpeg PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Close monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimpeg PM 2mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Medical advice is necessary. Glimpeg PM 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glimpeg PM 2mg/500mg/15mg Tablet SR :
Should you forget to take your Glimpeg PM 2mg/500mg/15mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Glimpeg PM 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently